Lilly J R, Giles G, Hurwitz R, Schroter G, Takagi H, Gray S, Penn I, Halgrimson C G, Starzl T E
Pediatrics. 1971 Mar;47(3):548-57.
Fifty-seven patients were treated with renal homotransplantation from 1½ to 7⅔ years ago; 23 patients were 12 years or younger and the other 34 patients were 13 to 18. Family members (usually parents) were the primary donors in 45 cases. Unrelated volunteers or cadavers donated the other 12 homografts. Immunosuppression was with azathioprine and prednisone, and in some cases also with ALG. Forty-two of the 57 recipients survived for at least 1 year. Additional deaths occurred at 17½ and 19 months leaving 40 recipients (70.2%) alive. Six survivors had successful retransplantation following late failure of their original homografts. Control of rejection was not particularly different than in adult cases. “Homograft glomerulonephritis” was found in chronically tolerated transplants, but no more frequently than in older patients. Many postoperative problems in the pediatric age group were the consequence of retardation of growth caused either by pre-existing uremia or by the need for high dose postoperative steroid therapy, orthopedic accidents such as femoral and vertebral fractures, and psychiatric complications which led to two suicides. In spite of these difficulties, the meaningful rehabilitation that was obtained in the chronic survivors makes us regard pediatric patients as favorable candidates for therapy with renal transplantation.
57例患者在1年半至7又2/3年前接受了同种异体肾移植;其中23例患者年龄在12岁及以下,另外34例患者年龄在13至18岁。45例患者的主要供体为家庭成员(通常是父母)。另外12例同种异体移植的供体为非亲属志愿者或尸体。免疫抑制采用硫唑嘌呤和泼尼松,部分病例还加用了抗淋巴细胞球蛋白(ALG)。57例受者中有42例存活至少1年。另有患者分别在17年半和19个月时死亡,最终有40例受者(70.2%)存活。6例存活者在其最初的同种异体移植肾后期失功后成功进行了再次移植。排斥反应的控制与成人病例并无特别差异。在长期耐受的移植肾中发现了“同种异体移植肾小球肾炎”,但其发生率并不高于年长患者。小儿年龄组的许多术后问题是由既往存在的尿毒症或术后需要高剂量类固醇治疗导致的生长发育迟缓、股骨和椎骨骨折等骨科意外以及导致2例自杀的精神并发症所致。尽管存在这些困难,但慢性存活者获得的有意义的康复使我们认为小儿患者是肾移植治疗的合适人选。